Investor Relations

Home / Investors

Overview.

THC Therapeutics, Inc. is a publicly traded fully reporting company to the SEC trading under ticker symbol THCT. THC Therapeutics is a forward-thinking company focusing on revenue-based Cannabis sector business development. The company is developing their proprietary product the dHydronator®, a sanitizing herb dryer.

The main function of the dHydronator® is to greatly accelerate drying time and destroy surface bacteria and contaminants. The dHydronator® is proven to reduce the drying time from 10-14 days to less than 14 hours while reducing microbial contaminant load from failing to passing levels. The Company also plans to focus some of its future operations on participation in Cannabis testing lab facilities, Cannabis infused beverages & edible markets. The Company is seeking partnerships, mergers and acquisitions in the Cannabis industry.

Latest News

THCT
OTC

VOLUME
CHANGE

Investor Updates.

Keep up to date on THC Therapeutics News. Simply fill out your
email below and you will be added to our email newsletter.


By clicking submit, you are agreeing to our Terms & Conditions